Ruibao Ren, MD, PhD

Deputy director, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Ruibao Ren received his M.D. from Beijing Medical College (currently the Peking University, Health Sciences Center) in 1983 and Ph.D. from College of Physicians and Surgeons, Columbia University, New York in 1992. As a student, he studied transgenic mice that expressed the human poliovirus receptor — a model for human poliomyelitis. He did his postdoctoral training in the laboratory of Nobel Laureate David Baltimore at The Rockefeller University, where he discovered that SH3 domains mediate protein–protein interactions by binding to small, linear, proline-rich motifs. He joined the faculty of the Department of Biology, Brandeis University in 1994 and was promoted to the rank of tenured professor in 2008. His laboratory has generated mouse models for human leukemia and used molecular and chemical biology approaches to discover and develop novel targeted therapies for cancer. He served as a member of Hematopoiesis Study Section, NIH, the Leukemia and Lymphoma Society Career Development Program Subcommittee, and as the chairman of Integration Panel of Chronic Myelogenous Leukemia Research Program, of the Department of Defense. He has received Junior Faculty Awards from American Cancer Society and March of Dimes, Basil O’Connor as well as The Leukemia and Lymphoma Society Scholar Award. He is currently the deputy director of Shanghai Institute of Hematology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, the deputy editor of the Journal of Hematology and Oncology and editorial board member of Journal of Biological Chemistry and Frontiers of medicine.